BiologX

BiologX is a private biopharma company focused on developing and manufacturing affordable recombinant human insulin. The company positions itself around proprietary production methods intended to increase output and reduce manufacturing cost while maintaining USP-grade quality standards. Its lead focus appears to be regular human insulin for broad diabetes use, with public materials also referencing potential future work in insulin analogues. BiologX is an early-stage company and, based on available public information, does not appear to have disclosed clinical-stage assets or commercialized products. The company has promoted a mission centered on improving insulin access, particularly in the United States.